ID: ALA566921

Max Phase: Preclinical

Molecular Formula: C10H9N3O2

Molecular Weight: 203.20

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Nc1ncc(Oc2ccccc2)c(=O)[nH]1

Standard InChI:  InChI=1S/C10H9N3O2/c11-10-12-6-8(9(14)13-10)15-7-4-2-1-3-5-7/h1-6H,(H3,11,12,13,14)

Standard InChI Key:  HSTJPDNRLDGHJI-UHFFFAOYSA-N

Associated Targets(non-human)

Dihydropteroate synthase 77 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 203.20Molecular Weight (Monoisotopic): 203.0695AlogP: 1.14#Rotatable Bonds: 2
Polar Surface Area: 81.00Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.67CX Basic pKa: 0.79CX LogP: 0.77CX LogD: 0.61
Aromatic Rings: 2Heavy Atoms: 15QED Weighted: 0.77Np Likeness Score: -0.14

References

1. Hevener KE, Yun MK, Qi J, Kerr ID, Babaoglu K, Hurdle JG, Balakrishna K, White SW, Lee RE..  (2010)  Structural studies of pterin-based inhibitors of dihydropteroate synthase.,  53  (1): [PMID:19899766] [10.1021/jm900861d]

Source